HR1305-118

Introduced

To direct the Secretary of Health and Human Services, in consultation with the Secretary of State, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes.

118th Congress Introduced Mar 1, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill provides international strategy for development of qualified pandemic or epidemic products. It relies on definition changes, appropriations, reporting requirements, and compliance mandates. The main policy areas are Foreign Policy, Foreign Affairs, Environment, and Healthcare.

Who Benefits and How

Patients and health care consumers affected by the bill could gain revenue opportunities, Foreign businesses and cross-border trade participants affected by the bill could gain revenue opportunities, and Foreign affairs agencies and foreign-policy stakeholders affected by the bill could gain revenue opportunities.

Who Bears the Burden and How

Federal, state, or local agencies responsible for implementing the clause would take on compliance duties.

Key Provisions

  • Provides international strategy for development of qualified pandemic or epidemic products.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill provides international strategy for development of qualified pandemic or epidemic products.

Key Policy Areas

Foreign Policy, Foreign Affairs, Environment, Healthcare

Primary Purpose

The bill provides international strategy for development of qualified pandemic or epidemic products.

Policy Domains

Foreign Policy Foreign Affairs Environment Healthcare

Whole bill

Identified Gains
  • Patients and health care consumers affected by the bill
  • Foreign businesses and cross-border trade participants affected by the bill
  • Foreign affairs agencies and foreign-policy stakeholders affected by the bill
  • Environmental and public health interests affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Patients and health care consumers affected by the bill:
Environmental and public health interests affected by the bill:
Foreign businesses and cross-border trade participants affected by the bill:
Foreign affairs agencies and foreign-policy stakeholders affected by the bill:
Identified Costs
  • Federal, state, or local agencies responsible for implementing the clause
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Federal, state, or local agencies responsible for implementing the clause:

Legislative Progress

Introduced
Introduced Committee Passed
Mar 1, 2023

Mr. Levin (for himself, Mr. Ferguson, Mr. McGovern, and Mr. …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Foreign Policy Foreign Affairs Environment Healthcare

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology